The rapidly changing biotechnology environment, influenced by globalisation, competition, financial pressures and the advancement of new technologies, has had a dramatic impact on the small to medium biotechnology firm.
Commercialisation is the process of taking an idea and turning it in to a successful outcome in the market, whether it is a product, service, process or organisational system.
The Australian Institute for Commercialisation (AIC), a division of QMI Solutions, believes that commercialisation should also include knowledge diffusion, consulting services and contract research rather than just the linear transfer of technology or intellectual property (IP).
Today, the key factors needed to ensure small to medium biotechnology firms survive the discontinuous change are: entrepreneurship, innovation and collaboration. The following five strategies for successful commercialisation are founded on these the three key factors of success.
To read the full, original article click on this link: The Australian Institute for Commercialisation - Five strategies for successful commercialisation in biotechnology
